Kidney function decline associated with proton pump inhibitors: results from the ELSA-Brasil cohort

Abstract Objective Investigate the longitudinal association of use and time of use of proton pump inhibitors (PPI) with incidence of chronic kidney disease (CKD) and kidney function change. Methods Prospective study with 13,909 participants from baseline (2008–2010) and second wave (2012–2014) of th...

Full description

Bibliographic Details
Main Authors: Andrêza Soares dos Santos, Sara Teles de Menezes, Isabella Ribeiro Silva, William Neves Oliveira, Mariana Linhares Pereira, José Geraldo Mill, Sandhi Maria Barreto, Roberta Carvalho Figueiredo
Format: Article
Language:English
Published: BMC 2023-09-01
Series:BMC Nephrology
Subjects:
Online Access:https://doi.org/10.1186/s12882-023-03300-4
_version_ 1797577531274035200
author Andrêza Soares dos Santos
Sara Teles de Menezes
Isabella Ribeiro Silva
William Neves Oliveira
Mariana Linhares Pereira
José Geraldo Mill
Sandhi Maria Barreto
Roberta Carvalho Figueiredo
author_facet Andrêza Soares dos Santos
Sara Teles de Menezes
Isabella Ribeiro Silva
William Neves Oliveira
Mariana Linhares Pereira
José Geraldo Mill
Sandhi Maria Barreto
Roberta Carvalho Figueiredo
author_sort Andrêza Soares dos Santos
collection DOAJ
description Abstract Objective Investigate the longitudinal association of use and time of use of proton pump inhibitors (PPI) with incidence of chronic kidney disease (CKD) and kidney function change. Methods Prospective study with 13,909 participants from baseline (2008–2010) and second wave (2012–2014) of the ELSA-Brasil (mean interval between visits = 3.9 years (1.7–6.0)). Participants answered about use and time use of the PPI in the two weeks prior the interview. Renal function was assessed by glomerular filtration rate estimated by the Collaboration Equation for the Epidemiology of Chronic Kidney Disease. Values below 60ml/min/1.73 m² in wave 2 were considered incident CKD. Associations between PPI use and time of use at baseline and incident CKD and decline in renal function were estimated, respectively, by logistic regression and linear models with mixed effects, after adjusting for confounders. Results After adjustments, PPI users for more than six months had an increased risk of CKD compared to non-users. Compared to non-users, users PPIs for up to six months and above six months had greater decline in kidney function over time. Conclusion This cohort of adults and elderly, after a mean interval of 3.9 years, PPI use and initial duration were associated with kidney function change between visits.
first_indexed 2024-03-10T22:09:40Z
format Article
id doaj.art-bb4d2ef872244f7cb7086d099c807965
institution Directory Open Access Journal
issn 1471-2369
language English
last_indexed 2024-03-10T22:09:40Z
publishDate 2023-09-01
publisher BMC
record_format Article
series BMC Nephrology
spelling doaj.art-bb4d2ef872244f7cb7086d099c8079652023-11-19T12:39:18ZengBMCBMC Nephrology1471-23692023-09-0124111010.1186/s12882-023-03300-4Kidney function decline associated with proton pump inhibitors: results from the ELSA-Brasil cohortAndrêza Soares dos Santos0Sara Teles de Menezes1Isabella Ribeiro Silva2William Neves Oliveira3Mariana Linhares Pereira4José Geraldo Mill5Sandhi Maria Barreto6Roberta Carvalho Figueiredo7Postgraduate Program in Health Sciences, Universidade Federal de São João del-ReiLongitudinal Study of Adult Health – ELSA-Brasil, Medical School & Clinical Hospital/EBSERH, Universidade Federal de Minas GeraisPostgraduate Program in Health Sciences, Universidade Federal de São João del-ReiPostgraduate Program in Health Sciences, Universidade Federal de São João del-ReiPostgraduate Program in Health Sciences, Universidade Federal de São João del-ReiDepartment of Physiological Sciences & University Hospital, Universidade Federal do Espírito SantoMedical School & Clinical Hospital/EBSERH, Universidade Federal de Minas GeraisPostgraduate Program in Health Sciences, Universidade Federal de São João del-ReiAbstract Objective Investigate the longitudinal association of use and time of use of proton pump inhibitors (PPI) with incidence of chronic kidney disease (CKD) and kidney function change. Methods Prospective study with 13,909 participants from baseline (2008–2010) and second wave (2012–2014) of the ELSA-Brasil (mean interval between visits = 3.9 years (1.7–6.0)). Participants answered about use and time use of the PPI in the two weeks prior the interview. Renal function was assessed by glomerular filtration rate estimated by the Collaboration Equation for the Epidemiology of Chronic Kidney Disease. Values below 60ml/min/1.73 m² in wave 2 were considered incident CKD. Associations between PPI use and time of use at baseline and incident CKD and decline in renal function were estimated, respectively, by logistic regression and linear models with mixed effects, after adjusting for confounders. Results After adjustments, PPI users for more than six months had an increased risk of CKD compared to non-users. Compared to non-users, users PPIs for up to six months and above six months had greater decline in kidney function over time. Conclusion This cohort of adults and elderly, after a mean interval of 3.9 years, PPI use and initial duration were associated with kidney function change between visits.https://doi.org/10.1186/s12882-023-03300-4Proton pump inhibitorsChronic kidney diseaseKidney functionPharmacovigilancePharmacoepidemiology
spellingShingle Andrêza Soares dos Santos
Sara Teles de Menezes
Isabella Ribeiro Silva
William Neves Oliveira
Mariana Linhares Pereira
José Geraldo Mill
Sandhi Maria Barreto
Roberta Carvalho Figueiredo
Kidney function decline associated with proton pump inhibitors: results from the ELSA-Brasil cohort
BMC Nephrology
Proton pump inhibitors
Chronic kidney disease
Kidney function
Pharmacovigilance
Pharmacoepidemiology
title Kidney function decline associated with proton pump inhibitors: results from the ELSA-Brasil cohort
title_full Kidney function decline associated with proton pump inhibitors: results from the ELSA-Brasil cohort
title_fullStr Kidney function decline associated with proton pump inhibitors: results from the ELSA-Brasil cohort
title_full_unstemmed Kidney function decline associated with proton pump inhibitors: results from the ELSA-Brasil cohort
title_short Kidney function decline associated with proton pump inhibitors: results from the ELSA-Brasil cohort
title_sort kidney function decline associated with proton pump inhibitors results from the elsa brasil cohort
topic Proton pump inhibitors
Chronic kidney disease
Kidney function
Pharmacovigilance
Pharmacoepidemiology
url https://doi.org/10.1186/s12882-023-03300-4
work_keys_str_mv AT andrezasoaresdossantos kidneyfunctiondeclineassociatedwithprotonpumpinhibitorsresultsfromtheelsabrasilcohort
AT saratelesdemenezes kidneyfunctiondeclineassociatedwithprotonpumpinhibitorsresultsfromtheelsabrasilcohort
AT isabellaribeirosilva kidneyfunctiondeclineassociatedwithprotonpumpinhibitorsresultsfromtheelsabrasilcohort
AT williamnevesoliveira kidneyfunctiondeclineassociatedwithprotonpumpinhibitorsresultsfromtheelsabrasilcohort
AT marianalinharespereira kidneyfunctiondeclineassociatedwithprotonpumpinhibitorsresultsfromtheelsabrasilcohort
AT josegeraldomill kidneyfunctiondeclineassociatedwithprotonpumpinhibitorsresultsfromtheelsabrasilcohort
AT sandhimariabarreto kidneyfunctiondeclineassociatedwithprotonpumpinhibitorsresultsfromtheelsabrasilcohort
AT robertacarvalhofigueiredo kidneyfunctiondeclineassociatedwithprotonpumpinhibitorsresultsfromtheelsabrasilcohort